ABSTRACT
RhoGDI proteins have been implicated in several human cancers; changes in their expression levels have shown pro- or anti-tumorigenic effects. Pancreatic Ductal Adenocarcinoma (PDAC) is a complex pathology, with poor prognosis, and most patients die shortly after diagnosis. Efforts have been focused on understanding the role of RhoGDI's in PDAC, specially, RhoGDI1 and RhoGDI2. However, the role of RhoGDI3 has not been studied in relation to cancer or to PDAC. Here, we characterized the expression and functionality of RhoGDI3 and its target GTPases, RhoG and RhoB in pancreatic cell lines from both normal pancreatic tissue and tissue in late stages of PDAC, and compared them to human biopsies. Through immunofluorescences, pulldown assays and subcellular fractionation, we found a reduction in RhoGDI3 expression in the late stages of PDAC, and this reduction correlates with tumor progression and aggressiveness. Despite the reduction in the expression of RhoGDI3 in PDAC, we found that RhoB was underexpressed while RhoG was overexpressed, suggesting that cancerous cells preserve their capacity to activate this pathway, thus these cells may be more eager to response to the stimuli needed to proliferate and become invasive unlike normal cells. Surprisingly, we found nuclear localization of RhoGDI3 in non-cancerous pancreatic cell line and normal pancreatic tissue biopsies, which could open the possibility of novel nuclear functions for this protein, impacting gene expression regulation and cellular homeostasis.
Subject(s)
Carcinoma, Pancreatic Ductal/pathology , Pancreatic Ducts/pathology , Pancreatic Neoplasms/pathology , rho GTP-Binding Proteins/metabolism , rho Guanine Nucleotide Dissociation Inhibitor gamma/metabolism , rhoB GTP-Binding Protein/metabolism , Cell Line, Tumor , Enzyme Activation , Fluorescent Antibody Technique , Humans , rho GTP-Binding Proteins/analysis , rho Guanine Nucleotide Dissociation Inhibitor gamma/analysis , rhoB GTP-Binding Protein/analysisABSTRACT
PURPOSE OF INVESTIGATION: To evaluate the distribution of GTPases RhoA, RhoB, and Cdc42 in cervical intraepithelial neoplasias (CIN) and invasive neoplasias of the uterine cervix. MATERIALS AND METHODS: samples of neoplastic lesions of the uterine cervix of 44 patients were classified in: CIN I (n = 10), CIN II (n = 10), CIN III (n = 09), and invasive carcinoma (n = 15). Antibodies anti-RhoA, anti-RhoB, and anti-Cdc42 were used and staining was classified as: negative, mild, moderate, and intense positive. RESULTS: When compared with dysplastic cells, superficial cells showed: higher expression of RhoB in CIN I (p = 0.0018), and lower expression of Cdc42 in CIN I (p = 0.0225). The authors observed higher expression of RhoA (p = 0.0002) and RhoB (p = 0.0046) in CIN dysplastic cells when compared with invasive carcinoma cells. CONCLUSIONS: GTPases Rho may be involved with the regulation of biological processes, important to the progression of cervical neoplasias. Probably, RhoA is important for maintenance of cell differentiation and RhoB protects cells from malignant cervical neoplasia.
Subject(s)
Uterine Cervical Dysplasia/pathology , Uterine Cervical Neoplasms/pathology , rhoA GTP-Binding Protein/physiology , rhoB GTP-Binding Protein/physiology , Adult , Female , Humans , Immunohistochemistry , Middle Aged , Neoplasm Invasiveness , Neoplasm Staging , Uterine Cervical Neoplasms/enzymology , cdc42 GTP-Binding Protein/analysis , rhoA GTP-Binding Protein/analysis , rhoB GTP-Binding Protein/analysis , Uterine Cervical Dysplasia/enzymologyABSTRACT
Acquired resistance to cisplatin represents a major obstacle to an efficient chemotherapy. We found downregulation of RhoB expression in cisplatin-resistant tumor cell lines from different origin. In cisplatin-resistant laryngeal carcinoma subline overexpression of farnesylated or geranylgeranylated RhoB increased cisplatin-induced cell death, while silencing of RhoB expression diminished sensitivity of parental HEp-2 cells via decreased cellular accumulation of cisplatin. However, since RhoB silencing in additional tumor cell lines did not alter their sensitivity to cisplatin, we can assume that RhoB downregulation does not provide general protective role in cell response to cisplatin. Nevertheless, gene therapy involving restoration of RhoB expression might improve the efficiency of cisplatin treatment, especially in patients with laryngeal carcinoma that acquired resistance to this chemotherapeutic drug.
Subject(s)
Antineoplastic Agents/pharmacology , Cisplatin/pharmacology , Laryngeal Neoplasms/drug therapy , rhoB GTP-Binding Protein/physiology , Cell Line, Tumor , Down-Regulation , Drug Resistance, Neoplasm , Humans , Laryngeal Neoplasms/metabolism , rhoB GTP-Binding Protein/analysis , rhoB GTP-Binding Protein/antagonists & inhibitorsABSTRACT
Hematopoietic stem cells (HSCs) are generally defined by their dual properties of pluripotency and extensive self-renewal capacity. However, a lack of experimental clarity as to what constitutes extensive self-renewal capacity coupled with an absence of methods to prospectively isolate long-term repopulating cells with defined self-renewal activities has made it difficult to identify the essential components of the self-renewal machinery and investigate their regulation. We now show that cells capable of repopulating irradiated congenic hosts for 4 months and producing clones of cells that can be serially transplanted are selectively and highly enriched in the CD150(+) subset of the EPCR(+)CD48(-)CD45(+) fraction of mouse fetal liver and adult bone marrow cells. In contrast, cells that repopulate primary hosts for the same period but show more limited self-renewal activity are enriched in the CD150(-) subset. Comparative transcriptome analyses of these 2 subsets with each other and with HSCs whose self-renewal activity has been rapidly extinguished in vitro revealed 3 new genes (VWF, Rhob, Pld3) whose elevated expression is a consistent and selective feature of the long-term repopulating cells with durable self-renewal capacity. These findings establish the identity of a phenotypically and molecularly distinct class of pluripotent hematopoietic cells with lifelong self-renewal capacity.
Subject(s)
Cell Separation/methods , Flow Cytometry/methods , Hematopoietic Stem Cells/cytology , Animals , Animals, Congenic , Antigens, CD/analysis , Antigens, Differentiation/analysis , Bone Marrow Cells/cytology , Cell Division , Cells, Cultured/transplantation , Gene Expression Profiling , Hematopoietic Stem Cell Transplantation , Hematopoietic Stem Cells/metabolism , Immunophenotyping , Leukocyte Common Antigens/analysis , Liver/cytology , Liver/embryology , Mice , Mice, Inbred C57BL , Phospholipase D/analysis , Radiation Chimera , Receptors, Cell Surface/analysis , Signaling Lymphocytic Activation Molecule Family Member 1 , rhoB GTP-Binding Protein/analysis , rhoB GTP-Binding Protein/genetics , von Willebrand Factor/analysis , von Willebrand Factor/geneticsABSTRACT
The acrosome reaction (AR) is an exocytotic process of spermatozoa, and an absolute requirement for fertilization. During AR, actin polymerization is necessary in the equatorial and postacrosomal regions of guinea pig sperm for spermatozoa incorporation deep into the egg cytoplasm, but not for plasma membrane (PM) fusion nor the early steps of egg activation. To identify the mechanisms involved in this sperm actin polymerization, we searched for the protein members, known to be involved in a highly conserved model, that may apply to any cellular process in which de novo actin polymerization occurs from G protein activation. WASP, Arp 2/3, profilins I and II, and Cdc42, RhoA and RhoB GTPases were localized by indirect immunofluorescence (IIF) in guinea pig spermatozoa and their presence corroborated by Western blotting. WASP and profilin II were translocated to the postacrosomal region (Arp2/3 already were there) in long-term capacitated and acrosome-reacted spermatozoa, at the same time as actin polymerization occurred. These events were inhibited by GDP-beta-S and promoted by lysophosphatidic acid (LPA) and GTP-gamma-S, a small GTPase inhibitor and two activators, respectively. By immunoprecipitation, Cdc42-WASp association was identified in capacitated but not in noncapacitated gametes. Polymerized actin in the postacrosomal region is apparently anchored both to the postacrosomal perinuclear theca region and the overlying PM. Results suggest that GTPases are involved in sperm actin polymerization, in the postacrosomal region and the mechanism for polymerization might fit a previously proposed model (Mullins, 2000: Curr Opin Cell Biol 12:91-96).
Subject(s)
Acrosome Reaction/physiology , Actins/metabolism , Spermatozoa/metabolism , rho GTP-Binding Proteins/physiology , Acrosome/chemistry , Acrosome/drug effects , Acrosome/metabolism , Actin-Related Protein 2 , Actin-Related Protein 3 , Animals , Contractile Proteins/analysis , Contractile Proteins/physiology , Cytoskeletal Proteins/analysis , Cytoskeletal Proteins/metabolism , Guanosine 5'-O-(3-Thiotriphosphate)/pharmacology , Guinea Pigs , Lysophospholipids/pharmacology , Male , Microfilament Proteins/analysis , Microfilament Proteins/physiology , Profilins , Proteins/analysis , Proteins/physiology , Sperm Capacitation/drug effects , Sperm Capacitation/physiology , Spermatozoa/chemistry , Spermatozoa/drug effects , Wiskott-Aldrich Syndrome Protein , cdc42 GTP-Binding Protein/analysis , cdc42 GTP-Binding Protein/physiology , rho GTP-Binding Proteins/analysis , rhoA GTP-Binding Protein/analysis , rhoA GTP-Binding Protein/physiology , rhoB GTP-Binding Protein/analysis , rhoB GTP-Binding Protein/physiologyABSTRACT
Transcriptional responses of J774 murine macrophage-like cells to infection with Yersinia enterocolitica were evaluated with oligonucleotide microarrays interrogating 12 488 genes and expressed sequence tags. Virulence plasmid (pYV)-cured yersiniae induce a transcriptional programme resembling a general inflammatory response. pYV-carrying yersiniae translocating the Yersinia outer proteins (Yops) impact on this transcriptional programme in two ways: first, by suppressing this inflammatory response and, secondly, by inducing sustained expression of a distinct set of genes with known silencing functions. These tranquilizing patterns of gene expression could be confirmed by real-time reverse transcription polymerase chain reaction, are stable upon reduction in bacterial load and could also be reproduced in BALB/c-derived bone marrow macrophages. Prestimulation of macrophages with interferon (IFN)-gamma, but not with interleukin (IL)-4, induces partial resistance against pYV-mediated transcriptional tranquilization. The first effect, suppression of the inflammatory programme, is mediated by YopP, whereas no YopH- or YopM-regulated genes could be identified under our stringent statistical criteria. The bacterial protein responsible for the second effect, induction of silencing genes, remains elusive. We suggest that Yersinia enterocolitica might use two independent mechanisms to inhibit macrophage inflammatory responses at the transcriptional level.
Subject(s)
Adhesins, Bacterial/physiology , Macrophages/metabolism , Macrophages/microbiology , Transcription, Genetic , Yersinia enterocolitica/pathogenicity , Animals , Apoptosis , Bacterial Outer Membrane Proteins/chemistry , Gene Expression Profiling , Gene Expression Regulation , Genes, Bacterial , Hypoxanthine Phosphoribosyltransferase/analysis , Interferon-gamma/pharmacology , Interleukin-4/pharmacology , Mice , Mice, Inbred BALB C , Oligonucleotide Array Sequence Analysis , Protein Tyrosine Phosphatases/chemistry , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction , Virulence , rhoB GTP-Binding Protein/analysisABSTRACT
Small GTPases are monomeric guanine nucleotide binding proteins of 20-25 kDa mass. Rho GTPases belong to the Ras superfamily of small GTPases. The small GTPases of the Rho family have been shown to participate in the organisation of the actin cytoskeleton and signal transduction pathways leading to gene transcription. Recent evidence suggests that Rho family GTPases may play an important role in synaptic communication in the brain, and particularly in synatic plasticity. In this study the distribution of RhoA, RhoB, RhoG, Cdc42, and Rac1 was investigated in hippocampal and cerebellar tissue of adult rat brain using immunohistochemical techniques. Previous studies suggest that distribution of Rho family mRNA is uniform throughout these structures. Here we provide evidence for differences in expression of these proteins between different regions of the hippocampus, and between the molecular and granular layers in the cerebellum. These differences may prove important with regard to the physiological functions of Rho family GTPases.
Subject(s)
Cerebellum/enzymology , Hippocampus/enzymology , rhoB GTP-Binding Protein/analysis , Age Factors , Animals , Blotting, Western , GTP Phosphohydrolases/analysis , Immunohistochemistry , PC12 Cells , Rats , cdc42 GTP-Binding Protein/analysis , rac1 GTP-Binding Protein/analysis , rhoA GTP-Binding Protein/analysisABSTRACT
While there is a number of studies on the effects of Rho GTPases on the actin-based cytoskeleton in higher eukaryotes, studies in protozoans are rather limited. The problem seems to be intriguing since the structure of protozoan cytoskeletons is distinct from most vertebrate cells. By blocking endogenous Rho family proteins of highly motile Amoeba proteus with C3 transferase and antibodies against human RhoA and Rac1, we tried to assess the in vivo role of these proteins in amoebae. In migrating amoebae, both proteins are concentrated in the cortical layer and seem to colocalize with filamentous actin. Endogenous Rac1, but not RhoA, is accumulated in the perinuclear cytoskeleton. Blocking Rac- or Rho-like proteins caused distinct and irreversible changes in the locomotive shape of the examined amoebae and significant inhibition of their migration. Amoebae microinjected with anti-Rac1 antibodies were contracted, shortened, and developed only few wide pseudopodia. More pronounced changes were observed in cells treated with anti-RhoA antibodies. They exhibited an atypical locomotion not leading to their effective displacement. After treatment with 50 microg of C3 transferase per ml, cells rapidly contracted and almost completely rounded up, became refractile with the granules beaten into a dense mass, detached from the surface and died. Ten times lower concentration of the enzyme caused similar changes as the inhibition of endogenous RhoA-like protein. These results indicate that Rho family-based regulation plays a key role in amoebic migration.
Subject(s)
Amoeba/enzymology , rac GTP-Binding Proteins/physiology , rho GTP-Binding Proteins/physiology , Amoeba/cytology , Amoeba/physiology , Animals , Carrier Proteins/analysis , Cell Movement , Humans , Microfilament Proteins/analysis , rac1 GTP-Binding Protein/analysis , rac1 GTP-Binding Protein/physiology , rhoA GTP-Binding Protein/analysis , rhoA GTP-Binding Protein/physiology , rhoB GTP-Binding Protein/analysis , rhoB GTP-Binding Protein/physiologyABSTRACT
Astrocytic tumors are the most common human brain tumors. Establishment of tumor grade is a key determinant both in the choice of a therapeutic approach and in the prognosis. The diagnosis of astrocytic tumors is currently determined following histopathological analysis. The identification of molecular markers would offer a complementary tool for characterizing tumors with respect to their clinical behavior. In this study we determined the expression levels of 3 small GTP binding proteins (RhoA, RhoB and Rac1), of their inhibitor RhoGDI and of caveolin-1 in 24 human astrocytic tumors of grades I to IV. Our results demonstrated that the expression of RhoA and RhoB decreased significantly in all brain tumors studied and was inversely related with tumor of grade II to IV malignancy. The amount of caveolin-1 immunodetected was not significantly different from normal brain samples while the Rac1 expression level was diminished in astrocytic tumors of grades III and IV. Our finding that RhoA and RhoB expression levels are correlated to tumor malignancy suggests that they may serve as novel and efficient diagnostic markers for astrocytic brain tumors of histological grade II to IV and complement currently applied histopathological analysis.